Skip to main content

Eli Lilly gets FDA approval for new obesity drug

Zepbound helped patients lose up to 48 pounds on average in clinical trials.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.